Literature DB >> 21947614

Serotonin and molecular neuroimaging in humans using PET.

Anne Saulin1, Markus Savli, Rupert Lanzenberger.   

Abstract

The serotonergic system is one of the most important modulatory neurotransmitter systems in the human brain. It plays a central role in major physiological processes and is implicated in a number of psychiatric disorders. Along with the dopaminergic system, it is also one of the phylogenetically oldest human neurotransmitter systems and one of the most diverse, with 14 different receptors identified up to this day, many of whose function remains to be understood. The system's functioning is even more diverse than the number of its receptors, since each is implicated in a number of different processes. This review aims at illustrating the distribution and summarizing the main functions of the serotonin (5-hydroxytryptamin, 5-HT) receptors as well as the serotonin transporter (SERT, 5-HTT), the vesicular monoamine transporter 2, monoamine oxidase type A and 5-HT synthesis in the human brain. Recent advances in in vivo quantification of these different receptors and enzymes that are part of the serotonergic system using positron emission tomography are described.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21947614     DOI: 10.1007/s00726-011-1078-9

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  35 in total

Review 1.  PET tracers for serotonin receptors and their applications.

Authors:  J S Dileep Kumar; J John Mann
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2014

2.  Differential modulation of the default mode network via serotonin-1A receptors.

Authors:  Andreas Hahn; Wolfgang Wadsak; Christian Windischberger; Pia Baldinger; Anna S Höflich; Jan Losak; Lukas Nics; Cécile Philippe; Georg S Kranz; Christoph Kraus; Markus Mitterhauser; Georgios Karanikas; Siegfried Kasper; Rupert Lanzenberger
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

3.  Acute tryptophan loading decreases functional connectivity between the default mode network and emotion-related brain regions.

Authors:  Yacila I Deza-Araujo; Philipp T Neukam; Michael Marxen; Dirk K Müller; Thomas Henle; Michael N Smolka
Journal:  Hum Brain Mapp       Date:  2018-12-25       Impact factor: 5.038

4.  In vivo evaluation of [18F]FECIMBI-36, an agonist 5-HT2A/2C receptor PET radioligand in nonhuman primate.

Authors:  Jaya Prabhakaran; Kiran Kumar Solingapuram Sai; Francesca Zanderigo; Harry Rubin-Falcone; Matthew J Jorgensen; Jay R Kaplan; Katharine I Tooke; Akiva Mintz; J John Mann; J S Dileep Kumar
Journal:  Bioorg Med Chem Lett       Date:  2016-11-16       Impact factor: 2.823

5.  Escitalopram reduces attentional performance in anxious older adults with high-expression genetic variants at serotonin 2A and 1B receptors.

Authors:  Eric J Lenze; David Dixon; Petra Nowotny; Francis E Lotrich; Peter M Doré; Bruce G Pollock; Anthony L Hinrichs; Meryl A Butters
Journal:  Int J Neuropsychopharmacol       Date:  2012-04-17       Impact factor: 5.176

6.  Synthesis and Evaluation of Pyridyloxypyridyl Indole Carboxamides as Potential PET Imaging Agents for 5-HT2C Receptors.

Authors:  Fanxing Zeng; Jonathon A Nye; Ronald J Voll; Leonard Howell; Mark M Goodman
Journal:  ACS Med Chem Lett       Date:  2018-02-05       Impact factor: 4.345

7.  Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor.

Authors:  Franz X Vollenweider; Alan Anticevic; Katrin H Preller; Joshua B Burt; Jie Lisa Ji; Charles H Schleifer; Brendan D Adkinson; Philipp Stämpfli; Erich Seifritz; Grega Repovs; John H Krystal; John D Murray
Journal:  Elife       Date:  2018-10-25       Impact factor: 8.140

8.  Synthesis and evaluation of methylated arylazepine compounds for PET imaging of 5-HT(2c) receptors.

Authors:  Michael L Granda; Stephen M Carlin; Christian K Moseley; Ramesh Neelamegam; Joseph B Mandeville; Jacob M Hooker
Journal:  ACS Chem Neurosci       Date:  2012-12-07       Impact factor: 4.418

9.  Synthesis and in vitro evaluation of [18F]FECIMBI-36: A potential agonist PET ligand for 5-HT2A/2C receptors.

Authors:  Jaya Prabhakaran; Mark D Underwood; J S Dileep Kumar; Norman R Simpson; Suham A Kassir; Mihran J Bakalian; J John Mann; Victoria Arango
Journal:  Bioorg Med Chem Lett       Date:  2015-07-20       Impact factor: 2.823

Review 10.  In-vivo human brain molecular imaging with a brain-dedicated PET/MRI system.

Authors:  Zang Hee Cho; Young Don Son; Eun Jung Choi; Hang Keun Kim; Jeong Hee Kim; Sang Yoon Lee; Seiji Ogawa; Young Bo Kim
Journal:  MAGMA       Date:  2012-08-03       Impact factor: 2.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.